GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion. Post navigation Donald L. Barlett, 88, Dies; Prize Winning Reporter Bared CorruptionTrump Keeps the Tax Cut Promises Coming, Now for Americans Abroad
staff